Location History:
- Central Scotland, GB (2004)
- Edinburgh, GB (2004)
- Newhouse-Scotland, GB (2010)
- Scotland, GB (2010)
Company Filing History:
Years Active: 2004-2010
Title: The Innovative Contributions of Jordi Mestres
Introduction
Jordi Mestres is a notable inventor based in Scotland, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system disorders. With a total of 4 patents to his name, his work has the potential to impact many lives.
Latest Patents
Mestres' latest patents include innovative compounds that address various medical conditions. One of his notable inventions is the 1-arylsulfonyl-3-substituted indole and indoline derivatives, which are useful in treating central nervous system disorders. This invention relates to derivatives that can be used in pharmaceutical compositions for conditions such as psychosis, schizophrenia, manic depression, neurological disorders, cognitive enhancement, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, and Huntington's disease. Another significant patent involves 16α-methyl or ethyl substituted estrogens, which are steroidal compounds designed for estrogen receptor α selective treatment.
Career Highlights
Throughout his career, Jordi Mestres has worked with prominent companies in the pharmaceutical industry. He has been associated with Akzo Nobel N.V. and N.V. Organon, where he contributed to various innovative projects. His expertise in the field has allowed him to develop groundbreaking solutions for complex medical issues.
Collaborations
Mestres has collaborated with several professionals in his field, including Gerrit Herman Veeneman and Eduard Willem De Zwart. These collaborations have further enhanced his research and development efforts, leading to the successful creation of his patented inventions.
Conclusion
Jordi Mestres is a distinguished inventor whose work in pharmaceuticals has the potential to transform the treatment of central nervous system disorders. His innovative patents and collaborations reflect his commitment to advancing medical science.